[HTML][HTML] Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms
C Stonesifer, S Corey, S Ghanekar, Z Diamandis… - Progress in …, 2017 - Elsevier
Ischemic stroke is a leading cause of death worldwide. A key secondary cell death
mechanism mediating neurological damage following the initial episode of ischemic stroke …
mechanism mediating neurological damage following the initial episode of ischemic stroke …
Neuroinflammation, stem cells, and stroke
S Anthony, D Cabantan, M Monsour, CV Borlongan - Stroke, 2022 - Am Heart Assoc
Stroke remains a significant unmet clinical need with few treatment options that have a very
narrow therapeutic window, thereby causing massive mortality and morbidity in the United …
narrow therapeutic window, thereby causing massive mortality and morbidity in the United …
Post-stroke inflammation and the potential efficacy of novel stem cell therapies: focus on amnion epithelial cells
Ischemic stroke is a debilitating disease for which there are currently no effective treatments
besides the clot-buster, tissue plasminogen activator (t-PA), which is administered to less …
besides the clot-buster, tissue plasminogen activator (t-PA), which is administered to less …
Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury
B Bonsack, S Corey, A Shear, M Heyck… - CNS neuroscience & …, 2020 - Wiley Online Library
Ischemic stroke and traumatic brain injury (TBI) comprise two particularly prevalent and
costly examples of acquired brain injury (ABI). Following stroke or TBI, primary cell death …
costly examples of acquired brain injury (ABI). Following stroke or TBI, primary cell death …
Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms
Recent evidence suggests that neural stem/precursor cells (NPCs) promote recovery in
animal models with delayed neuronal death via a number of indirect bystander effects. A …
animal models with delayed neuronal death via a number of indirect bystander effects. A …
Efficacy of stem cell-based therapies for stroke
Stroke remains a prevalent disease with limited treatment options. Available treatments offer
little in the way of enhancing neurogenesis and recovery. Because of the limitations of …
little in the way of enhancing neurogenesis and recovery. Because of the limitations of …
Cell therapy for chronic stroke
LR Wechsler, D Bates, P Stroemer… - Stroke, 2018 - Am Heart Assoc
2 Stroke May 2018 produce a host of angiogenic factors. 23–26 The enhancement of
endogenous neurogenesis stimulated by brain injury has been shown for mesenchymal …
endogenous neurogenesis stimulated by brain injury has been shown for mesenchymal …
Neural stem cell therapy for stroke: A multimechanistic approach to restoring neurological function
Abstract Introduction Neural stem cells (NSCs) have demonstrated multimodal therapeutic
function for stroke, which is the leading cause of long‐term disability and the second leading …
function for stroke, which is the leading cause of long‐term disability and the second leading …
Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here
This review covers the pathogenesis of ischemic stroke and future directions regarding
therapeutic options after injury. Ischemic stroke is a devastating disease process affecting …
therapeutic options after injury. Ischemic stroke is a devastating disease process affecting …
Mesenchymal stem cells: therapeutic outlook for stroke
O Honmou, R Onodera, M Sasaki, SG Waxman… - Trends in molecular …, 2012 - cell.com
Adult bone marrow-derived mesenchymal stem cells (MSCs) display a spectrum of
functional properties. Transplantation of these cells improves clinical outcome in models of …
functional properties. Transplantation of these cells improves clinical outcome in models of …